Omnicell, Inc. (NASDAQ:OMCL) updated its first quarter earnings guidance on Wednesday. The company provided earnings per share guidance of $0.00-0.04 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.38. The company issued revenue guidance of $150-155 million, compared to the consensus revenue estimate of $179.88 million.Omnicell also updated its FY17 guidance to $1.32-1.42 EPS.

Several equities research analysts recently commented on the company. Zacks Investment Research raised Omnicell from a strong sell rating to a hold rating in a research note on Tuesday, February 7th. Oppenheimer Holdings, Inc. set a $46.00 target price on Omnicell and gave the stock a buy rating in a research note on Thursday, October 27th. Benchmark Co. raised their target price on Omnicell from $39.00 to $55.00 and gave the stock a buy rating in a research note on Tuesday, December 6th. Cantor Fitzgerald assumed coverage on Omnicell in a research note on Thursday, January 5th. They set an overweight rating and a $40.00 target price for the company. Finally, Dougherty & Co assumed coverage on Omnicell in a research note on Thursday, January 19th. They set a buy rating and a $44.00 target price for the company. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Omnicell has a consensus rating of Buy and a consensus target price of $43.38.

Shares of Omnicell, Inc. (NASDAQ:OMCL) opened at 37.95 on Friday. Omnicell, Inc. has a 52 week low of $25.06 and a 52 week high of $40.50. The firm has a market cap of $1.39 billion, a PE ratio of 174.08 and a beta of 0.76. The firm has a 50-day moving average price of $34.97 and a 200-day moving average price of $35.65.

Omnicell (NASDAQ:OMCL) last posted its quarterly earnings data on Wednesday, February 15th. The company reported $0.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.41 by $0.04. Omnicell had a return on equity of 10.74% and a net margin of 1.24%. On average, equities research analysts predict that Omnicell, Inc. will post $1.55 earnings per share for the current year.

“Omnicell, Inc. (OMCL) Issues Q1 Earnings Guidance” was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this report on another publication, it was stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this report can be read at

Omnicell Company Profile

Omnicell, Inc (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence.

5 Day Chart for NASDAQ:OMCL

Receive News & Ratings for Omnicell Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell Inc. and related companies with's FREE daily email newsletter.